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1 Introduction
This doctoral thesis is investigating the effect of in utero exposure to filaria
antigens on the CD4+ T cell distribution in cord blood. There is increasing
evidence that immune priming of the fetus already starts in utero. Maternal
infections can influence the developing immune system of the fetus independently
of whether vertical transmission is taking place [1]. Therefore especially in the
developing world, with high prevalence for chronic infections during pregnancy,
the fetus is exposed to a variety of antigens through the infections experienced by
its mother [1]. In certain territories a common infection also present in pregnant
women is filariasis. The filarial parasite is rarely transmitted vertically, but it
has strong immunomodulatory abilities and several studies have demonstrated
evidence that it is leading to sensitization in utero [2, 3, 4]. Epidemiological
studies have shown that children born to filaria infected mothers are more
susceptible to filaria infection [2, 3, 4]. There is even evidence that this immune
modulation can extend to third party antigens [1, 5]. For example it has been
shown that children born to filaria infected mothers have a higher risk of mother
to child transmission of human immunodeficiency virus (HIV) and a lower immune
response to vaccination [4, 6, 7].
Currently it is not well understood how exactly the in utero exposure affects the
cellular immune response. For this reason the present thesis questioned the
influence of filarial infection during pregnancy on the CD4+ T cell populations
in cord blood.
1.1 Filaria infection in the developing world
Filariasis is an infection mainly occurring in the developing world and is also
endemic in the Central-African country Gabon where this study was carried out.
This leaves amongst others pregnant women at high risk for this infection [8].
While infections like malaria and HIV are of great interest in the scientific
community filariasis is an infection less well studied and there is a lack in broad
epidemiological data. It is estimated that world wide there are between 3-13
million people infected with L. loa [9] and 114 million may be infected with M.
perstans [10]. L. loa is endemic to the rainforests of western and central Africa
from a latitude of 8-10o North to 5o South. It is most common in the Republic
of Congo, the Democratic Republic of Congo, Cameroon, Equatorial Guinea,
the Central African Republic, Nigeria and Gabon. In a recent survey using the
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rapid assessment procedure for loiasis (identified as RAPLOA), which combines
a history of eye worms with the level of endemicity of the infection, it was
estimated that nearly 30 million people live in high to intermediate risk areas with
a prevalence of eye worm history exceeding 20% [11].
M. perstans infection is a disease not linked to a clear clinical picture and only very
few studies have been carried out to evaluate the epidemiology of M. perstans.
It has been estimated that 114 million people may be infected and as many as
581 million people in about 33 countries are at risk of infection in Africa alone.
In endemic areas its prevalence during pregnancy can be up to 20% [1, 10]. M.
perstans is endemic to a large portion of Sub-Saharan Africa, from Senegal to
Uganda and south to Zimbabwe, as well as in Central and South America, from
Panama to Argentina [10].
1.2 Loa loa and Mansonella perstans
Filariasis is a disease caused by tissue-dwelling nematodes (roundworms) of the
superfamily Filaroidea. Currently 8 filarial nematodes that use humans as their
definitive host are known. They can be differentiated into three groups according
to the habitat of the adult worm in its vertebrae host. The group located in the
lymph system contains Wucheria bancrofti, Brugia malayi and Brugia timori. The
subcutaneous group includes Loa loa, Mansonella streptocerca and Onchocerca
volvulus. The group living in the serous cavities holds Mansonella perstans and
Mansonella ozzardi.M. perstans and L. loa are the two endemic species in Gabon
and therefore the ones this thesis will focus on [12].
1.2.1 Loa loa
L. loa, often referred to as the African eye worm, was first described in 1770 by
the french surgeon Mongin in the Carabean (Santo Domingo), who observed the
worm passing a girls eye. The first microfilariae (mf) were only discovered in 1890
by Stephan McKenzie [13].
Life-cycle The infective larvae are transmitted to the host by the bite of an
infected female fly of the Chrysops species. In the following 12 months these
larvea develop into white threadlike adult worms, which migrate through the
subcutaneous tissue (including the subconjunctiva from where the name eye
worm originates) at a rate of up to 1cm/min. Adult worms grow to a size of 3-7cm
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x 4mm and may live up to 17 years. In case of bisexual infections mf are produced
and released into the bloodstream [14]. The mf produced by L. loa are sheathed
and can be found in spinal fluid, urine, sputum, peripheral blood and in the lungs.
Mf have diurnal periodicity and are found circulating in the peripheral blood during
the day, but at night are in the vascular parts of the lungs and are non-circulatory
[15]. This diurnal periodicity coincides with the feeding patterns of the principal
vectors Chrysops silacea and Chrysops dimidiata. During another blood meal
the mf can reenter the vector, loose their sheaths, penetrate the flies midgut and
migrate to the thoracic muscle where they develop from the first stage larvae
(L1-larvae) to the infective third stage larvae (L3-larvae). During the next blood
meal these L3-larvae can again be transmitted to the next human host (Figure 1)
[15].
Disease The majority of infected people in endemic areas are asymptomatic
even though usually high levels of mf can be found in the blood. The symptoms
are predominantly allergic reactions including pruritus, urticaria, and transient
migratory swellings called Calabar swellings. All of those are mainly caused
by the immunological reaction of the host. Symptomatic patients often without
detectable mf in blood present with eosinophilia (often exceeding 3000/µl),
hypergammaglobulinemia, increased serum IgE-levels and a strong humoral and
cellular immune response to filarial antigens.
The most common complication is renal involvement including immune complex
glomerulonephritis or mechanical trauma due to filtration of blood-born mf. Up
to 30% of the patients present with hematuria or proteinuria, which may be
transiently exacerbated by treatment. Before introduction of diethylcarbamazine
in 1947 encephalitis was the most serious complication associated with the
presence of mf in the cerebrospinal fluid. Other less common complications
of loiasis include entrapment neuropathy, psychiatric disturbances, arthritis,
lymphadenitis, hydrocele, pleural effusion, retinal artery occlusion, posterior
uveitis, macular retinopathy, blindness, and endomyocardial fibrosis.
The first line treatment of L. loa recommended by theWHO is diethylcarbamazine.
Alternative drugs are ivermectin and albendazol [16].
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Figure 1: L. loa life-cycle [17]
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1.2.2 Mansonella perstans
Life-cycle M. perstans is transmitted only by female biting midges of the genus
Culicoides. When the midge bites a human the infective L3-larvae enter through
the wound into the human. Over the following 9-12 months they mature to adult
filariae. The adult male and female worms live in the serous cavities of the body
(mainly peritoneal and pleural cavities less frequent in the pericardium) and can
measure up to 3-8cm x 120µm. In case of bisexual infections the female worm can
produce mf that are released into the bloodstream. Those mf are then ingested by
the vector during the blood meal and migrate through it’s stomach to the thoracic
muscle where further development to initially non-infective L1-larvae and later on
to infective L3-larvae takes place (Figure 2) [10, 14].
Disease Other as previously assumed M. perstans infections are not always
asymptomatic and their presentation can be similar to that of L. loa. They can
cause transient angioedema and pruritus of the arms, face and other bodyparts
simular to the Calabar swellings of loiasis. Another common clinic presentation
is urticaria. Less commonly observed are fever, headache, arthralgias and
pain of the right upper quadrant. Rare complications are pericarditis, hepatitis,
meningoencephalitis and neuropsychic disturbances. Occular granulomata and
intraocular lesions as well as migration of adult worms through the subconjunctiva
have been reported [14]. At the moment there is no ideal treatment forM. perstans
infection. Different treatment strategies have been tested, but all with limited
efficacy [10].
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Figure 2: Mansonella perstans life-cycle [18]
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1.3 Brief overview of the T cell mediated immunity
The immune defense to infection is often categorized into the innate immune
response providing an unspecific but immediate protection against invading
pathogens and the adaptive immune response providing a very specific and long
lasting protection against pathogens, but takes a longer time to develop. The T
cell response is part of the adaptive immune system [19].
The three major characteristics of the adaptive immune response are an exquisite
specificity, the ability to generate a immunological memory and that it is highly
adaptive and able to respond to unlimited numbers of molecules. For better
understanding it can be separated into two major arms: the humoral immunity
and the cellular immunity. The humoral immunity involves antibodies produced by
B lymphocytes, while in the cellular immunity T lymphocytes play the central role
[19].
1.3.1 The development of T lymphocytes
The T lymphocytes progenitor cells originate from the hematopoietic stem cells
in the bone marrow from where they migrate to the thymus. In the thymus they
undergo further maturation and the process of positive and negative selection,
resulting in mature T lymphocytes. Every mature T cell expresses a unique
T cell receptor (TCR) making it sensitive to one specific antigen. T cells with
receptors incapable to react with the major histocompatibility complex (MHC) and
auto-reactive T cells are detected and destroyed during the process of positive
and negative selection. It is estimated that an individual processes 107-109 T cell
clones each with an individual TCR and at least ensuring partial coverage for
every antigen encountered. According to the protein chains that compose the
TCR T cells can be divided into ↵ :   (95%) and   :   (5%) T cells.
1.3.2 T cell mediated immunity
↵ :   T cells are of high importance for the immune response to viruses, fungi,
parasites and intracellular bacteria. T cells regulate the activities of B cells, T
cells and other cells participating in the immune response. They act as effector
cells of the antigen-specific cell-mediated immunity and provide help for antibody
production by B cells. During a process known as antigen processing and
presentation the entering pathogen is processed into component peptides that
bind to a structural framework on the cell surface known as human lymphocyte
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antigen (HLA). While all nucleated cells have the ability to process and present
antigens only a few are specialized antigen presenting cells (APC), these
include dendritic cells (DC), macrophages and B-lymphocytes. The presented
peptide/HLA-complex can then be recognized by individual T cells leading to their
activation [19].
↵ :   T lymphocytes and their subsets T lymphocytes can be further
categorized by their surface expression of either CD4 or CD8. The CD8+
("cytotoxic") T cells recognize antigenic peptides presented by HLA class 1
molecules (HLA-A, HLA-B and HLA-C) and are able to directly kill infected cells
by producing pore-forming molecules called perforins or by triggering apoptosis.
The CD4+ lymphocytes help to suppress or to regulate immune responses
by producing cytokines and providing co-stimulatory signals that support the
activation of CD8+ lymphocytes. They recognize the HLA class 2 molecules
(HLA-DR, HLA-DP and HLA-DQ) [19].
CD4+ cells can be subdivided into T helper (Th) cells including Th1, Th2, Th17
cells [20] and the regulatory T (Treg) cells (Figure 3). There is evidence for the
assumption that each Th subset is involved in the immune response against a
certain subset of microorganisms. Th1 cells are of importance in the defense
against intracellular microorganisms in general and mycobacteria in particular.
Th2 cells are of importance in parasitic infections and Th17 cells seem to play an
important role in the defense against extracellular bacteria, some fungi as well as
parasitic infections [21]. The Treg cells main function is to modulate or suppress
the immune response [22, 23, 24]. On this context the exact circumstances
leading to maturation of the subsets is not well understood. Whether a Th1, Th2,
Th17 or Treg response develops is determined by antigens, the cytokine milieu
and the APCs (Figure 3).
Th1 cells The polarization of Th0 cells to Th1 cells is promoted by Interleukin-12
(IL-12) and the marker Th1 cytokines are IL-2, Interferon gamma (IFN- )
and tumor necrosis factor alpha (TNF↵). Th1 cells promote the production
of opsonizing antibodies (e.g. IgG1), the activation of macrophages and
induce cellular cytoxity all leading to elimination of intracellular microorganisms.
Additionally they are of importance in the delayed type hypersensitivity reactions.
Overall the Th1 cells are pro-inflammatory [25, 26, 27]. They can be classified by
the presence of the transcription factor Tbet [28]. IL-12 leads to the activation of
STAT4 that then activates Tbet. The activation of Tbet then induces the secretion
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of IFN  [29].
Th2 cells The polarization of Th0 cells to Th2 cells is promoted by IL-4 and
the major Th2 effector cytokines are IL-4 and IL-13. Those are important for the
IgE and IgG4 synthesis and stimulate eosinophil development to help mediate
immunity against parasitic infections [30, 31]. Also they are the hallmark cells
in atopic disease [25, 26, 27]. They can be classified by the presence of the
transcription factor GATA-3 [28]. GATA3 induces the differentiation of Th0 cells
to Th2 cells, while at the same time suppressing their differentiation towards Th1
cells. It has also been shown to promote the secretion of IL-4, IL-5 and IL-13 by
regulating gene expression [32].
Th17 cells The polarization of Th0 cells to Th17 cells is promoted by IL-1 and
IL-6 and the major Th17 effector cytokine is IL-17. IL-17 induces the production
of pro-inflammatory cytokines and chemokines and also recruits neutrophiles.
The Th17 cells are involved in the early response to extracellular pathogens
and are also of importance in autoimmunity, tissue inflammation as well as the
neutrophile predominant forms of asthma [33, 34, 35, 36]. They can be classified
by the presence of the transcription factor ROR t [37]. That plays an important
regulatory role in reducing apoptosis of undifferentiated T cells and promoting
their differentiation to Th17 cells [38].
Regulatory T cells The modulation of the immune response by the Treg cells
is achieved via different mechanisms including secretion of inhibitory cytokines
(IL-10, transforming growth factor beta (TGF ) and IL-35), cytolytic enzymes and
suppressive molecules, metabolic disruption, expression of surface receptors that
can influence dendritic cell function and an induction of target cell senescence
[39, 40, 41, 42]. The dominant cytokines for Treg induction are TGF-  and IL-2.
These lead to an activation of STAT5 that leads to an activation of the transcription
factor Foxp3 [43, 44]. The activation of Foxp3 leads to the secretion of the Treg
effector cytokines which are: IL-10, TGF-  and IL-35 In mice two different types
of Treg cells have been identified. The "natural" Treg cells and the "induced" Treg
cells. In humans data on Treg cells is less complete and the exact characteristics
are still being determined. The natural Treg cells are identified as "CD4+CD25high
and Foxp3+" and appear to be the prominent subset in helminth infection [45].
This study focuses on natural Treg cells as previous studies conducted by our
group have unveiled the important role they play in filaria infection [46].
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Figure 3: Th subsets [47]
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1.4 T cells in newborns
Already at the end of the first trimester of gestation T and B lymphocytes and
APCs can be detected in the fetal blood [1].
The T cell development in the fetus starts at about six weeks of gestation with the
arising of the thymus from the 3rd brachial arch. Over the next 2-3 weeks lymphoid
cells migrate first from the yolk sac and the fetal liver later from the bone marrow
to colonize the fetal thymus [48, 49]. Already at 12 weeks of gestation the thymus
is organized into cortical and medullary regions and prothymocytes start dividing,
rearranging their TCR genes and undergoing positive and negative selection to
form T cells [50, 51, 52, 53]. These T cells migrate to the peripheral lymphoid
organs at about 14 weeks of gestation [54].
In contrast to the humoral immunity the T cell mediated immunity is not transferred
from mother to child. Therefore newborns rely exclusively on their own T cells.
Still there are differences between the distribution and function of those T cells
compared to adult blood:
In cord blood compared to adult blood the total lymphocytes ( 5400 cells/µl) as
well as the total T cell numbers ( 3100 cells/µl) are increased. The numbers
decline to adult level by 6-7 years of age. Also the CD4+ T Cells contribute to
a higher proportion of the T cells compared to the CD8+ T cells. The CD4+/CD8+
ratio at birth is about 4.9:1 declining to a ratio of 2:1 (like in adults) by four years
of age [55, 56].
During pregnancy the fetal cytokine responses are driven to a Th2 phenotype.
This is of importance as pro-inflammatory cytokines like from Th1 cells can lead
to abortion [57, 58]. Peripheral T cells in the fetus and the neonate are relatively
immature. Fetal and neonatal APCs can prime antigen specific T lymphocytes,
but their functional programs differ from those of adult cells restricting the
development of effector Th1 and possibly favoring the differentiation of regulatory
T cells and Th17 cells [1, 59].
1.5 Immunomodulation by Filariasis
Helminth infection has a strong effect on the immune system leading to a
polarization towards Th2 with high levels of the cytokines IL-4, IL-5 and IL-13
as well as high serum levels of IgE. Despite these initially strong Th2 responses
helminths are able to survive in their human hosts up to decades. This is believed
to be possible through the induction of immunoregulatory mechanisms leading
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to an hyporesponsiveness that prevents the elimination of the worm, but also
reduces the symptoms caused by the inflammation. This hyporesponsiveness
can also extend to third party antigens [5].
With adult filariae being able to live in their host up to 17 years, they are one of the
helminth species with one of the highest average lifespan. To cause this chronic
infection filariae had to develop different strategies to evade and down-regulate
the hosts immune system. Comparing filaria-infected visitors to the endemic
population it is conspicuous that visitors show more signs of inflammation,
reduced parasite loads together with a pro-inflammatory Th2 response [60]. This
indicates that in the endemic population a down regulation takes place reducing
the symptoms caused by an unaltered immune response.
Filariae induce regulatory T cells and alternatively activated macrophages, which
are able to suppress Th1 as well as Th2 responses [2, 61]. This parasite specific
anergy is primarily mediated by IL-10 and to a lesser extend by TGF-  and leads
to lower type 1 (IL-2 and INF- ) and type 2 (IL-5) cytokines [62]. Additionally
the regulatory T cells can induce B cells to secrete IgG4. IgG4 molecules are
capable of inhibiting IgE and IgG-mediated effector mechanisms leading to a
lower pathology [63]. Another effect induced by filariae is the down regulation
of DCs in the skin (Langerhans cells) by the L3-larvae. The L3-larvae impair the
ability of Langerhans cells to express MHC class I and II, IL-8 and other molecules
and leaves the cells inferior in their capacity to stimulate CD4+ T cells [2, 64, 65].
Several studies have shown evidence that the immune modulation caused by
filariasis already starts in utero as children born to filaria-infected mothers seem
to have increased susceptibility to filarial infection. It has been shown that in utero
exposure leads to a lower pro-inflammatory response, leading to fewer disease
manifestations and allowing higher infection rates as well as higher parasite loads
when the child gets infected [2, 3, 4]. In neonates exposed to filaria in utero
specific IgE can be detected in cord blood. Additionally in-vitro studies have
shown that their lymphocyte cytokine production to parasite antigen is similar
to that of their mother [1]. Typical characteristics that were found analyzing cord
blood comparing children from filaria infected vs. uninfected mothers are a lower
proliferation of T cells in the umbilical blood, a higher level of the down regulatory
cytokine IL-10 and higher levels of IgG4 [2]. A study carried out in Kenya showed
a reduced T lymphocyte responsiveness to mf antigens in children born to
mothers with lymphatic filariasis (no differences were seen in the stimulation with
adult worm antigens) [63]. Another study carried out in Uganda indicated that
maternal M. perstans infection during pregnancy was associated with stronger
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IL-10 responses to mycobacterial antigens and to vaccination with tetanus toxin
in exposed infants [6].
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2 Materials and Methods
2.1 Study design, study area and study population
This cross-sectional study was carried out at the “Centre de Recherche Médical
de la Ngounié” in Fougamou, Gabon from May 2011 till August 2011. “Centre de
Recherche Médical de la Ngounié” was founded in 2006 and is a subunit of the
"Centre de Recherches Médicales de Lambaréné", Gabon.
The Gabonese Republic is located in the western part of central Africa and
is sharing borders with Equatorial Guinea in the northwest, Cameroon to the
north and Republic of the Congo curving around the east and south. The west of
Gabon borders the Atlantic with a coastal line of about 800 km (Figure 4).
Gabon covers a land area of 267 667 km2 and an estimate from 2010 defines the
population at 1.545 million with almost half the population (675 000) living in the
capital Libreville. The population is composed of different ethnic groups of which
the Fang represent the largest. Most inhabitants speak an ethnic language next
to French, which is the official language.
Gabon has a tropical wet climate, with an average annual temperature of 26.6oC
and a constant humidity of 80-90%. The precipitation of about 2600 mm is split
between two rainy seasons, one short one from October until November, which
is marked with a higher rain intensity and a longer one from February till May.
85% of Gabon is covered with rainforest of which only small parts were cleared
for agriculture [66, 67].
Fougamou, a semi-rural town, is set in the province of Ngounié and lies
along the west bank of the Ngounié river. It is placed on the National Road 1
between Lambaréné and Moulia (Figure 4). It has a population of approximately
4100 inhabitants [68]. The research unit is located next to the small hospital
“Centre Médicale de Fougamou”. This hospital hosts four main departments:
General Medicine, Stomatology, Pediatrics and a Maternity ward.
Fougamou as well as its surrounding areas are highly endemic for the human
parasites L. loa, M. perstans and P. falciparum. A study published in 2011 by the
Centre International de Recherches Médicales de Franceville (CIRMF) describes
the overall prevalence in Gabon for L. loa at 22.4%, 10.2% for M. perstans and
3.2% for mixed infections [69]. CIRMF also published a paper describing the
prevalence of malaria at 6.2% in adults [70].
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The study took place in the framework of a study being performed in Fougamou
and called "Malaria in Pregnancy Preventive Alternative Drugs" (MiPPAD).
MiPPAD is a study funded by the European and Developing Countries Trial
Partnership (EDCTP) and is executed on four study sites, being Benin,
Gabon, Mozambique and Tanzania. The study is led by Prof. Clara Menéndez
(Barcelona Centre for International Health Research, Spain) and aims to
evaluate the safety, tolerability and efficacy of Mefloquin as an alternative drug
to Sulphadoxine-Pyrimethamine (SP) for Intermittent Preventive Treatment in
pregnancy (IPTp). By January 2012, the study ended recruitment, having enrolled
a total of 4,734 pregnant women, after screening 17,947 women [71, 72].
In the context of the MiPPAD study 30 pregnant women with and without filaria
infection were recruited and various blood samples were collected from the
mothers and the cord of the newborn babies (details see below).
After finishing the sample collection in Fougamou in August 2011 the frozen
samples were transported, for further analysis to the Leiden University Medical
Center (LUMC), Leiden, the Netherlands. The parasitological examinations were
carried out at the study site.
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Figure 4: Map of the Republic of Gabon [73]
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2.2 Study procedures
2.2.1 Recruitment of participants
This cross-sectional study was designed to examine the effect of maternal filaria
infection on the frequency of CD4+ T cell subsets in cord blood. For this purpose,
two study groups were formed namely, filaria-uninfected and filaria-infected
mothers. All participants were recruited within the MiPPAD study taking place
in Fougamou.
Inclusion and Exclusion criteria To exclude factors that might have an
influence on the T cells in cord blood, the following inclusion and exclusion criteria
were established as shown in Table 2.
Table 2: Inclusion and Exclusion criteria
Inclusion criteria Women included in the MiPPAD-Study
Women who signed the informed consent for MiPPAD and
MiPPADs axillary studies
Women who agreed to an additional filarial screening
Women in child bearing age
Women from Fougamou and the surrounding villages
Exclusion criteria Women or newborns with serious clinical conditions
Cases of still-birth
Women with acute malaria infection at time of delivery
Placental malaria and malaria infection of the child
Women giving birth to twins
Birthweight lower than 2200 grams
Women infected with HIV
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2.2.2 Parasitological Examinations
All participants were screened for filaria, malaria, schistosomiasis and HIV. The
filaria status was evaluated for all women qualifying for inclusion. For this a 2.8
ml Ethylenediaminetetraacetic acid (EDTA) tube was used to drain blood from the
mothers whose date of delivery was expected within the next 2 months. Using the
leuko-concentration method these blood samples were screened for L. loa and
M. perstans [74].
The malaria, schistosomiasis and HIV screening was performed as a part of the
MiPPAD-study. For Malaria thick smears were taken at inclusion, delivery and
every time a woman presented with fever at an unscheduled visit. In this manner
it was possible to record all the malaria episodes during the pregnancy from the
moment the mother was enrolled in the MiPPAD-study. Besides the thick smear
of the mother at delivery smears were also taken from the cord blood and the
placenta to rule out placental malaria or malaria parasitemia in the newborn.
To evaluate the schistosomiasis status 10 milliliter (ml) of urine were collected
from each woman and searched for eggs using the Urine Filtration Method
recommended by the WHO [75].
Detection of microfilariae Pregnant women from the MiPPAD study, who were
close to their calculated date of delivery (expected date of delivery within 2
months), were screened for L. loa and M. perstans using the Leuko- (Knott’s-)
concentration method. A modified Knott’s concentration technique was applied
as followed: 2.5 ml anticoagulant EDTA blood was collected from the mother
and diluted 1:1 with 2% Saponin-solution in a conical tube in order to lyse
the erythrocytes. The samples were placed on a rolling/tilting mixer for 15
minutes, centrifuged (5 min at 500 acceleration (g)) and then the supernatant
was discarded. The pellet was placed on a microscope slide and covered with
a cover slip. Then the whole slide was examined under the microscope (10x
objective). The density of mf was calculated dividing the number of mf counted by
the amount of original blood used resulting in the number of mf per ml blood. The
parasite species were identified by their size and by the absence (M. perstans) or
presence of a sheath (L. loa). If needed toluidine-blue was used to make the mf
more visible [74].
Detection of Plasmodium falciparum To determine the malaria parasitemia a
thick smear was preformed using the Lambaréné method [76]. The study patients
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were pricked into their fingertip with a one-time use lancet. The first drop was
discarded and then 10 µl of blood were taken from the fingertip with a pipette
and distributed on a 2x1 cm area on a microscope slide. After drying the slide
was coloured with 10% Giemsa in buffered water at pH 7.1 for ten minutes.
Afterwards, the slide was rinsed with water and air dried. The parasite counting
was done using a light-optical microscope counting all parasites. The parasitemia
was defined as the number of parasites per µl (total parasites counted divided
by 10 equaled the parasites per µl). The same colored slide was checked for mf.
When mf were found, the parasitemia was also recorded as parasites per µl.
Diagnostic of Schistosoma haematobium At study inclusion 10 ml of urine
were collected in a single use cup to screen the mothers for Schistosoma
haematobium infection. A polycarbonate screen membrane filter was put in
a Plastic Swinney filter holder and 10 ml of urine were pressed through the
filter-system using a 10 ml syringe. Next the filter was carefully removed from
the filter-system, laid on a microscope slide and the whole filter was examined for
schistosomal eggs using the light microscope (10x objective). The sensitivity for
this method is described at 50% [77].
Detection of HIV A quantitative Polymerase Chain Reaction (PCR) for HIV was
performed at the study site to determine the viral load from the blood sample
collected at enrollment to the MiPPAD-Study.
Treatment All participants were treated according to the MiPPAD-protocol and
the guidelines at the study site. The women, who were found to be infected with
M. perstans or L. loa during the screening, were offered a treatment with 400
mg Albendazole per day for seven days starting one month after delivery. All the
treatments administered were recorded in the MiPPAD case report form.
2.2.3 Blood collection and hematological measurements
Cord blood collection 9 ml of heparinized cord blood was collected at delivery
to perform immunological examinations. The blood was drawn from the umbilical
vein attached to the placenta after the child was born and the umbilical cord has
been cut and clamped. For this the umbilical cord was disinfected using 70%
ethanol to rule out contamination with maternal blood.
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Hematological measurements An EDTA tube of 1.2 ml blood was collected
from the mothers at delivery and was used for a full blood count. This included
erythrocytes, leukocytes, hematocrit, hemoglobin, platelets, lymphocytes,
eosinophils, basophils, monocytes and neutrophils. The hemograms were
generated using the ABX Pentra 60. During the MiPPAD-screening, 1.5 ml of
capillary blood was collected for a HIV-test.
2.2.4 Immunological analysis
Cord Blood Mononucleated Cells (CBMC) Isolation The CBMC isolation was
performed following the protocol “LUMC 002.2: Peripheral Blood Mononuclear
Cell (PBMC) isolation” written by the department of parasitology at LUMC. The
protocol was last reviewed by Yvonne Kruize in March 2011.
The blood processing took place within 24 hours after delivery and 4.5 ml anti
coagulated cord blood from a heparinized vacutainer was used. The blood was
centrifuged in the vacutainer and plasma was taken from the blood-cell pellet
and frozen in a cryo vial. The blood cell pellet was then transferred to a 50
ml Falkon tube and diluted 1:1 with HBSS. After mixing 13 ml of 1.077-Ficoll
were carefully placed under the blood/HBSS-suspension. The suspension was
centrifuged without break at 1520 rounds per minute (rpm) for 25 minutes.
The interphase between Ficoll and HBSS containing the CBMC was transferred
carefully to another 50 ml Falcon tube. After two washing steps with HBSS the
pellet was re-suspended in 5 ml of 10% FCS/ IMDM and an estimate of the
number of cells isolated was calculated using the counting chamber. For this
the cells were stained with Türk stain, filled into the counting chamber and the
leukocytes in 25 squares were counted, including those touching the upper and
the left border and leaving out those touching the lower and the right border. From
this count, the number of cells per ml was calculated. The cells were then diluted
to reach a concentration of 1 million cells per 200 µl.
Cell-fixation using eBio-Science The eBioscience fixation was performed
following the protocol “LUMC 011.02: Ex-vivo fix-freezing cells by eBioscience”
written by the Department of Parasitology at LUMC. This protocol was last
reviewed by Linda Wammes in May 2010. 1 million of the isolated CBMC were
added to a well on a 96-well-plate. The plate was centrifuged (1200rpm, 4 min)
and the supernatant discarded. subsequently the cells were washed with PBS
and after centrifugation (1200 rpm, 4 min) the supernatant was again discarded.
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200 µl of eBioscience fixation buffer (1 part fixation/permeabilisation concentrate
plus 3 parts fixation/permeabilisation diluent) was added to the pellet and the
plate was incubated in the dark at 4 C for 60 minutes. After incubation 200 µl
PBS was added, the plate was centrifuged (1200 rpm, 4 min) and the supernatant
was discarded. 200 µl of freezing medium (RPMI: 10% FCS and 20% DMSO) was
added, and the cells were transferred to a cryotube to be frozen at  80  C freezer.
Thawing of cryopreserved Cells The thawing of cells was performed following
the protocol "LUMC 020: Thawing of cryo-preserved fixed cells", written by the
Department of Parasitology at LUMC. This protocol was last reviewed by Linda
Wammes in March 2011. The samples were thawed, stained and measured by
Fluorescence-activated cell sorting (FACS) at the same day. 5 ml tubes labeled
with the donors number and containing 1 ml of thawing medium (RPMI with
10% FCS) at room temperature were prepared. The samples were taken out
of the freezer and 0.5 ml of warm thawing medium was slowly added to each
sample. The thawed cells were transferred to the corresponding 5 ml tube and
centrifuged (1600 rpm, 5 min). The supernatant was discarded and the cells were
re-suspended in 2 ml PBS. After centrifugation, the FACS staining was applied.
FACS-Staining For the FACS-staining a T cell panel was established for which
surface and transcription markers were chosen to allow description of the cell
population. The markers were chosen according to current literature and previous
experience.
The FACS-staining was preformed using the protocols "LUMC 018.02:
Intracellular FACS-staining for eBioscience-fixed cells" written by the Department
of Parasitology at LUMC. This protocol was last revised by Kit Yeng Liu in June
2010.
For the staining of the samples a mix of fluorescent labeled antibodies Helios,
ROR t, T-bet, CD25, GATA3, FOXP3 and CD4 was prepared in staining buffer
(permealization buffer with 1% human Fc R-binding inhibitor) based on optimal
working dilutions. The antibody dilutions used for a single stain were prepared
in FACS buffer (PBS with 0.5% FCS and 2mM EDTA). Fluorescence Minus One
(FMO) were prepared for the ROR t, T-bet, GATA3 and FOXP3 antibodies (Figure
5). All steps involving staining were carried out in the dark.
As some of the T cell antigens are intracellular antigens a permeabilization step
was performed before staining. A V-bottom 96 well plate was prepared following a
layout created in advance (Figure 6). Following the layout, 200 000 cells per donor
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were added to corresponding wells. A cell-mix of all the filaria infected donors
and a mix of the filaria uninfected donors only was prepared and added to the
FMOs. Instead of cells compensation beads were added to the single stain wells
in respect to the antibodies used (Mouse- or Rat-Ig). The plate was centrifuged
(4 min, 1200 rpm) and the supernatant was discarded.
In order to stain the intracellular antigens 150 µl of permealization buffer (0.5
% Saponin in PBS) was added to the cells before the staining. The plate was
centrifuged again and the supernatant discarded.
30 µl of staining mix, single stain or FMO was added to the corresponding wells
and mixed by pipetting. The plates were incubated for 30 minutes in the dark
at 4oC. After incubation 150 µl of permealisation buffer was added to the cells
and the beads. The plates were centrifuged (4 min, 1200 rpm, 4oC) and the
supernatant discarded. 50µl of FACS buffer were added to each well and the
content was then transferred to 1.5 ml FACS insert tubes.
Channel'
' Flurochrome' Target' Isotype' Clone' End'dilution'
FL2$ PE$ RORγT$ Rat$IgG2a$ AFKJS49$ 1:150$
FL3$ PerP5.5$ Tbet$ Mouse$IgG1$ 4B10$ 1:320$
FL4$ PE4Cy7$ CD25$ Mouse$IgG1$k$ 2A3$ 1:160$
FL5$ APC$ $ $ $ $
FL6$ Eflour660$ GATA3$ Rat$IgG2b$k$ TWAJ$ 1:80$
FL7$ Eflour450$ FOXP3$ Rat$IgG2a$κ$ PCH101$ 1:100$
FL8$ V500$ CD4$ Mouse$IgG1$κ$ RPA4T4$ 1:40$
$ CD16/CD32$ $ $ $ 1:100$
$
Figure 5: Markers used for FACS-Analysis
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Figure 6: Plate arrangement for FACS-Staining
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Flowcytometry analysis The samples were measured using FACS-Canto II
with the FACS-Diva software following the Protocol "LUMC 022.01: Standard
Operating Procedure measuring samples manually with FACS-Canto" written by
the Department of Parasitology at LUMC. The protocol was last reviewed by Kit
Yeng Liu in May 2010. Before measuring the samples the machine was rinsed
and the fluidic start-up was preformed. Then the parameters and channels were
set and width and voltages adjusted. The unstained and single cell samples were
run first and according to those measurements compensation was performed.
Now the samples were acquired one by one and saved under the sample ID.
After the measurements it was noticed, that the data for the GATA3+ cells
was not usable, as the FACS machine was set up incorrectly for this specific
readout. It was set up to measure channels FL1, FL2, FL3, FL4, FL6, FL7 and
FL8, but not channel FL5. The original idea was to detect GATA3 staining in the
FL6 channel, but this was the wrong detector as the used marker eFluor660 has
to be detected using the FL5 channel. Therefore the GATA3 fluorescence could
not be measured and the fluorescence recorded in FL6 was just background
fluorescence and not due to GATA3. Thus no data about GATA3 was available.
FlowJo analysis The data gathered from FACS was analysed using FlowJo
version 9. For this, the data was imported into the FlowJo software. The gating
was performed as described below on one sample and then applied to all the
other samples to obtain a standardized result. If the applied gate clearly did not
match with the sample it was adjusted. For the selection of the gate, the single
stainings and FMOs were taken in account.
Gating strategy for T cells The cell populations to be identified using FlowJo
were the T helper cells (classified as the CD4+ population). From these cells
it was differentiated further in T regulatory cells (classified as CD4+, CD25high
and FOXP3+ cells), T helper 1 cells (classified as CD4+ and T-bet+ while being
ROR t ) and T helper 17 cells (classified as being CD4+ and ROR t+, while
being T-bet ). The CD4+ population was given as a percentage of the total
lymphocyte population, while all the other values were given as a percentage
of the CD4+ population.
The first gate set was the lymphocyte gate. For this the Forward Scatter Area
(FSC-A) was plotted against the Sidewards Scatter Area (SSC-A) and the
area where the lymphocytes are expected due to their size and granularity
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was selected. After selecting the lymphocytes, the lymphocyte doublets were
excluded by plotting once FSC-A against Forward Scatter Width (FSC-W) and
SSC-A against Sidewards Scatter Width (SSC-W). To find the CD4+ population
FSC-A was plotted versus the CD4 marker and the cloud with CD4 expression
was selected. For further gating only the CD4+ cells were used. To find the T
regulatory population CD25 was plotted against FOXP3 defining the T-regulatory
cells as CD25highFOXP3+ cells. To get the Th1 and Th17 populations first the
population being negative for the other marker was selected and then plotted
versus the marker searched for. A FlowJo gating example for T cells is given in
Figure 7.
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Figure 7: Gating example FlowJo
2.2.5 Data management and analysis
Collection of demographic data A questionnaire was completed for each
woman included. In the first section information about the mother comprising
age, area of habitation and number of former pregnancies and deliveries was
collected. The second section was about the current pregnancy including date
of last menstruation, diseases/complications during pregnancy and potential
medications received. The last section contained information about the newborn
comprising gestational age at delivery, sex, birth weight, length and head
circumference. The collected data were entered into an openClinica data base
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and included in the analysis later on to exclude other factors influencing the
results.
Statistical Analysis All the data was analyzed using IBM SPSS Statistics
Version 20. For this a SPSS data base was generated including the data gained
from the questionnaire and the data generated from FlowJo.
In case the data was normally distributed an independent sample t-test was
performed to compare continuous variables (for example percentage of T cell
subsets) between the groups ( for example filaria infected and uninfected or
malaria history in pregnancy and no malaria history). In case the data were not
normally distributed they were log transformed in order to get a distribution closer
to normality. Data that remained not normally distributed were compared using a
non parametric Man Whitney test. The same principle was applied to compare the
study groups. Moreover the chi-squared test was used for comparing proportions.
The correlation between two continuous variables was assessed using the
Spearman’s correlation test. A positive Pearson coefficient (r) indicated a positive
correlation between the two variables, while a negative Pearson coefficient
indicated a negative correlation.
Since P. falciparum infection during pregnancy has the potential to modulate the
immune system of the mother and could influence the one of the fetus we have
decided to correct for effect of filaria on the newborn immune response after
correcting for past episode of P. falciparum infection during pregnancy [78, 79, 80].
A multiple regression analysis was performed to see the independent effect of
filaria and malaria infection on the different T cell subsets. The association of
the two variables is given by the regression coefficient beta ( ) (+ = positve
association, - = negative association).
A linear regression analysis was performed to asses the association between
regulatory cells and the Th1 and Th17, first regardless of the filaria infection status
of the mother and secondary in newborns from filaria infected and uninfected
mothers separately. The strength of the association was determined by the level
of the regression coefficient  .
The level of significance was set at a p value below 0.05.
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2.2.6 Ethics
Ethical Approval In April 2010, the International Ethical Commission of
the Albert Schweitzer Hospital in Lambaréné ("Comité d’Ethique Régional
Indépendant de Lambaréné" (CERIL)) approved the study. The study was
conducted in compliance to the study protocol and the participants’ consent
was obtained according to the ethical principles stated in the Declaration of
Helsinki (stated by the World Medical Association at their 59th assembly in
October 2008 in Seoul). The applicable guidelines of "International Conference
on Harmonisation of Technical Requirements for Registration of Pharmaceuticals
for Human Use" (ICH), of Good Clinical Practice (GCP), and the applicable
regulations of Gabon were followed. A copy of the signed and dated informed
consent was given to the participants. The signed and dated original was retained
with the study records.
Informed Consent A signed enrollment informed consent (or thumb-printed
when the woman was illiterate) was obtained for the MiPPAD-Study before any
tests related to the study were carried out. Additionally an ancillary study informed
consent was signed by the women accepting to participate in this study. If the
woman was under 18, additionally, the signature of a legal guardian was obtained.
The informed consent covered the woman and the newborn.
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2.3 Materials
2.3.1 Apparatus
Table 3: Apparatus list
Apparatus name Manufacturer
Airstream R  Class II Biological Safety Cabinet ESCO, Singapore
Centrifuge Rotanta 460R/460RS Hettich Zentrifugen, Germany
FACS Canto BD Biosciences, US
ABX Pentra 60 HORBIA Medical, Japan
Water Still 2012 GFL R , Gesellschaft für
Labortechnik mbH, Germany
Precision balance 440 KERN, Germany
Roller Tubes Mixer Healthcares Technologies,
South Africa
Pipetboy acu Integra Biosciences,
Switzerland
Pipette 2-20µl Labmate; LM20 Abimed, Germany
Pipette 20-200 µl; Labmate; LM200 Abimed, Germany
Pipette 100-1000 µl; Labmate; LM1000 Abimed, Germany
Neubauer improved-Counting chamber LaborOptik, Germany
Refrigerator, 0 oC
Freezer, -80 oC
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2.3.2 Materials
Table 4: Material list
Material Manufacturer
Immunological Examinations
Falcon R  50 ml conic tube Becton Dickinson Labware, US
EasyLoad R  universal 1000µl Greiner Bio-one, Germany
EasyLoad R  universal 200µl Greiner Bio-one, Germany
10 ml Stripette Costar R  Corning Incorporated, US
Tranferpipette 3.5ml SARSTEDT, Germany
CryoTubeTMVials 1.8ml NuncTMA/S, Denmark
Cryo-Babies R  Roth, Germany
96-well plate Round, NunclonTMSurface NuncTMA/S, Denmark
FACS V-bottom F96 wells plate, non-sterile NuncTMA/S, Denmark
1.4 ml FACS insert tubes Micronic, Netherlands
FACS tubes BD-Bioscience, US
Reaction tubes, 1.5ml Greiner bio-one, Germany
1ml Sub-Q Becton Dickinson, France
Parasitological Examinations *
15ml Cellstar R  Tubes Greiner Bio-one, Germany
Microscope slide 76x26 mm ISO 8037/1 Langenbrinck, Germany
Cover slide 24x60 mm Dicke 0.13-0.18mm Langenbrinck, Germany
Plastic Swinney filter holders STERLITECH Corporations, UK
Polycarbonate screen membrane filters -13
mm diameter, 12 µm pore size
STERLITECH Corporations, UK
10 ml one time use syringes HA SA MED, Germany
Staining Jar
Blood sampling
BD Vacutainer R  Safety-LokTM21G Becton Dickinson, US
Multi-Adapter SARSTEDT, Germany
S-Monovette R  EDTA K/2,7 ml SARSTEDT, Germany
S-Monovette R  Li-Heparin NH4/ 5,5 ml SARSTEDT, Germany
S-Monovette R  Li-Heparin NH4/ 9 ml SARSTEDT, Germany
RAPI SWAP 70% Isopropyl Alcohol Jagat Diagnostics Pvt. Ltd. India
One-time-use gloves Latex Cooper Cooperation, France
Tourniquet
Cotton
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2.3.3 Chemicals
Table 5: Chemical list - 1
Chemical Manufacturer
CBMC Isolation
Ficoll-Amidotrizoaat (Ficoll) Apotheek AZL, Netherlands
Hanks’ Balanced Salt Solution (HBSS) GIBCO R , InvitrogenTM, US
Iscove’s Modified Dulbecco’s Medium (IMDM) GIBCO R , InvitrogenTM, US
Sodium-Penicillin G 100U/ml Astellas Pharma, Netherlands
Streptomycin 100µg/ml Sigma-Aldrich, Netherlands
Glutamate (2mM)/Pyruvate (1mM) Sigma-Aldrich, Netherlands
Fetal Bovine Serum (FCS) Greiner Bio-one, Austria
Tuerk-stain
eBioscience Fixation
Phosphate Buffered Saline (PBS) 10x Fresenius Kabi, Germany
eBio fixation/Permeabilization Diluent eBioscience, Canada
eBio fixation/Permeabilization Concentrate eBioscience, Canada
Dimethylsulfoxide (DMSO) MERCK, Germany
Parasitological Examinations *
Saponin powder Sigma, US
Tuerk-stain Merck, Germany
Giemsa-stain
Distilled water
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Table 6: Chemical list - 2
Chemical Manufacturer
FACS-Staining
Compensation Bead Anti-Rat/Hamster Ig BD-Bioscience, US
Compensation Bead Anti-Mouse Ig BD-Bioscience, US
Fc R-binding inhibitor eBioscience, Canada
Ethylenediaminetetraacetic acid (EDTA, 2mM) Sigma-Aldrich, US
Anti-ROR t, PE, Rat IgG2a eBioscience, Canada
Anti-T-bet, PerP5.5, Mouse IgG1 eBioscience, Canada
Anti-CD25, PE-Cy7, Mouse IgG1 BD-Bioscience, US
Anti-GATA3, Eflour660 Rat IgG2b eBioscience, Canada
Anti-FOXP3, Eflour450, Rat IgG2a eBioscience, Canada
Anti-CD4, V500, Mouse IgG1 BD-Bioscience, US
* Parasitological examinations for L. loa, M. perstans, P. falciparum and Schistosoma
haematobium.
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3 Results
3.1 Characteristics of the study population
A total of 30 pregnant women and their newborns were included in this study, of
whom 15 were infected with either L. loa orM. perstans and 15 were free of these
infections.
Considering the demographic characteristics both study groups were found to
be comparable at inclusion (Table 7). The proportion of primiparus mothers was
significantly higher in the uninfected group (0% in the infected group vs. 4% in
the uninfected one, p= 0.032). A similar higher proportion of male newborns were
born in the uninfected group (53% in the infected group vs. 87% in the uninfected
one, p= 0.046). The hemogram from the mothers showed that filaria-infected
mothers had significantly higher platelet counts (251x103/mm3 in infected vs.
172x103/mm3 in uninfected, p= 0.020) then the uninfected mothers. Also a trend
for lower Hematocrit (34.5% in infected vs. 38% in uninfected, p=0.056) and
Hemoglobin levels (11.08g/dl in infected vs. 12.27g/dl in uninfected, p=0.052) was
seen in the infected group. All of the mothers were free of malaria at the time of
delivery and two were found with S. haematobium infection (one in each group).
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Table 7: Comparison of study groups
 
 
 
 
 
 
 
Characterization Study 
Population 
Filaria 
infected 
Filaria 
uninfected p value 
Malaria episodes during 
pregnancy, N (%) 8 (53%) 5 (33%) 0.269# 
S. haematobium infections,  
N (%) 1 (7%) 1 (7%) 1# 
Age of mother at delivery in 
years: Mean (±SD) 
24.27 
(±7.54) 
25.47 
(±5.44) 0.621* 
Fougamou,  
N (%) 7 (47%) 5 (33%) Area 
Outside,  
N (%) 8 (53%) 10 (67%) 
0.456# 
Erythrocytes (x10⁶/mm³): 
Mean (±SD) 
4.29 
(± 0.52) 
4.47 
(± 0.99) 0.550* 
Leukocytes (x10³/mm³): 
Mean (±SD) 
7.93 
(± 3.13) 
8.87 
(± 2.67) 0.387* 
Hematocrit  (%): 
Mean (±SD) 
34.49 
(± 4.22) 
38.00 
(± 5.35) 0.056* 
Hemoglobin (g/dl): 
Mean (±SD) 
11.08 
(± 1.48) 
12.27 
(± 1.71) 0.052* 
Platelets (x10³/mm³): 
Mean (±SD) 
251.20 
(± 99.98) 
172.73 
(± 71.08) 0.020* 
Lymphocytes (x10³/mm³): 
Mean (±SD) 
2.91 
(± 1.00) 
2.34 
(± 0.81) 0.099* 
Eosinophils (x10³/mm³): 
Mean (±SD) 
0.72 
(± 0.70) 
0.85 
(± 0.49) 0.555* 
Basophils(x10³/mm³): 
Mean (±SD) 
0.05 
(± 0.03) 
0.05 
(± 0.02) 0.830* 
Monocytes (x10³/mm³): 
Mean (±SD) 
0.49 
(± 0.40) 
0.44 
(± 0.17) 0.686* 
Characteristics 
of the mothers 
Neutrophils (x10³/mm³): 
Mean (±SD) 
3.76 
(± 2.83) 
4.97 
(± 2.57) 0.237* 
Mean gestational age in 
months: Mean (±SD) 
37.24 
(± 3.26) 
37.80 
(± 3.75) 0.666* 
Mean birth weight in g: 
Mean (±SD) 
2843.33 
(± 413.81) 
2950.67 
(± 455.47) 0.505* 
Mean length at birth in cm: 
Mean (±SD) 
47.00 
(± 2.00) 
48.00 
(± 1.65) 0.147* 
Mean head circumference in 
cm: Mean (±SD) 
31.60 
(± 1.30) 
32.33 
(± 1.11) 0.108* 
Male, N (%) 8 (53%) 13 (87%) 
Characteristics 
of the child 
 
 
Sex of child 
Female, N (%) 7 (47%) 2 (13%) 
0.046# 
The categorical data was analyzed using the Pearson Chi Square test (marked #) while
the continuous data was compared using an independent sample t-test (marked *).
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3.2 Effect of demographic factors on the distribution of T cell
subsets
The independent sample t-test was used to evaluate the effect of the sex of child
and area of the mother living place, on the distribution of CD4+ cells and CD4+
cells expressing FOXP3 (Treg), Tbet (Th1) and Ror T (Th17) (Table 8).
No differences were seen in percentages of CD4+ cells, regulatory T cells, Th1
and Th17 cells between male and female children or considering the mothers
living place (Table 8). Comparing T cell subsets of the female children to those of
the male a trend for lower Th1 cells (0.01% in female vs. 0.17% in male, p=0.052)
was seen.
The effect of the influencing factors: maternal age, gestational age and
birth weight on the distribution of CD4+ cells and CD4+ cells expressing FOXP3,
Tbet and Ror T was analyzed using a correlation analysis (Table 8).
This analysis showed that the gestational age of the child had a significant
influence on the regulatory T cells and T helper subsets. Gestational age showed
a negative association with the regulatory T cells (Pearsons r= -0.477, p=0.008)
and a positive correlation with Th1 cells (Pearsons r=0.375, p=0.041) and Th17
cells (Pearsons r=0.437, p=0.016). The age of the mother and birth weight of the
child had no significant influence on the T cell subsets. There was a trend for
a negative correlation between maternal age and regulatory T cells (Pearsons
r=-0.322, p=0.083) and a trend for a positive correlation between maternal age
and Th1 cells (Pearsons r=0.329, p=0.076).
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Table 8: The distribution of T cell subsets of newborns in relation with
demographic factors and the infection status of their mother
 CD4+ T cells T reg cells Th1 cells Th17 cells  
Factor Categories 
Mean 
(± SD) P 
Mean 
(± SD) P 
Mean 
(± SD) P 
Mean 
(± SD) P 
Negative (15) 
43.87 
(± 2.88) 
2.34 
(± 0.19) 
0.14 
(± 1.15) 
0.16 
(± 1.17)  
Filaria 
Positive (15) 47.71 (± 2.76) 
0.344 
2.79 
(± 0.30) 
0.210 
0.16 
(± 1.26) 
0.564 
0.10 
(± 1.20) 
0.113 
No (17) 46.82 (± 2.90) 
2.26 
(± 0.21) 
0.17 
(± 1.20) 
0.13 
(± 1.17)  Malaria in 
pregnancy Yes(13) 44.43 
(± 2.68) 
0.561 
2.97 
(± 0.29) 
0.048 
0.12 
(± 1.17) 
0.246 
0.12 
(± 1.26) 
0.732 
Female (9) 44.62 
(± 4.93) 
2.52 
(± 0.38) 
0.1 
(± 1.20) 
0.14 
(± 1.29) Sex of child 
Male (21) 46.29 (± 2.00) 
0.709 
2.59 
(± 0.21) 
0.871 
0.17 
(± 1.17) 
0.052 
0.12 
(± 1.17) 
0.718 
Fougamou (12) 45.98 (± 3.21) 
2.49 
(± 0.28) 
0.14 
(± 1.20) 
0.12 
(± 1.20) 
Area 
Outside (18) 45.66 (± 2.62) 
0.940 
2.62 
(± 0.24) 
0.730 
0.15 
(± 1.20) 
0.674 
0.13 
(± 1.20) 
0.785 
 
 
 
 
 
 Independent sample t test - The means in each group ± the standard deviation are
given. p values are given to indicate the level of significance.
 CD4+ T cells T reg cells  Th1 cells Th17 cells 
Factor r p r p r p r p 
 
Age of mother 
 
0.138 0.468 -0.322 0.083 0.329 0.076 0.264 0.159 
 
Gestational age of the child 
 
-0.477 0.008 -0.323 0.081 0.375 0.041 0.437 0.016 
 
Birth weight of the child 
 
0.071 0.709 -0.039 0.838 -0.059 0.758 0.156 0.411 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Correlation analysis - The strength of the correlation between two variables is given by
the value of the Pearson coefficient (r) value. A positive r-value indicates a positive
correlation between the variables, while a negative r-value indicates a negative
correlation. p values are given to indicate the statistical significance of the correlation.
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3.3 Effect of filaria infection on the different T cell subsets
The independent sample t-test was used to evaluate the difference in mean
percentages of the filaria infected and uninfected group in CD4+ cells and CD4+
cells expressing FOXP3, Tbet and Ror T (Table 8).
Between the filaria infected and uninfected groups no significant difference was
found in percentage of CD4+ cells (47.71% in infected vs. 43.87% in uninfected,
p=0.344), Treg (2.79% in infected vs. 2.34% in uninfected, p=0.210), Th1 cells
(0.16% in infected vs. 0.14% in uninfected, p=0.564) and Th17 cells (0.10% in
infected vs. 0.16% in uninfected, p=0.113).
As several studies have shown that maternal malaria infection during pregnancy
can effect the fetal immune response including the T cells [78, 79, 80], a second
analysis was performed to correct the outcome for episodes of malaria during
pregnancy. This multiple regression analysis (Table 9) shows the independent
effect of filaria infection on the distribution of percentages of CD4+ cells and CD4+
cells expressing FOXP3, Tbet and Ror T.
Again filaria infection showed no significant effect on the percentages of CD4+
cells ( =3.504, p=0.404) and CD4+ cells expressing FOXP3 ( =0.625, p=0.073),
Tbet ( =0.060, p=0.334) and Ror T ( =-0.055, p=0.140).
3.4 Effect of malaria episode during pregnancy on the
distribution of T cell subsets
The independent sample t-test was used to evaluate the effect of episodes of
malaria during pregnancy on the mean percentages of CD4+ cells and CD4+
cells expressing FOXP3, Tbet and Ror T (Table 8).
Children born from mothers who experienced an episode of malaria during
pregnancy had a significantly higher percentage of regulatory T cells in
comparison to those who did not experience an episode of malaria during their
pregnancy (2.97% in the group with malaria episode vs. 2.26% in the group
without malaria episode, p= 0.048). No significant difference was seen between
the means of CD4+ cells (44.43% in the group with malaria episode vs. 46.82%
in the group without malaria episode, p=0.561), Th1 cells (0.12% in the group
with malaria episode vs. 0.17% in the group without malaria episode, p=0.246)
and Th17 cells (0.12% in the group with malaria episode vs. 0.13% in the group
without malaria episode, p=0.732).
In other studies an effect of filaria infection status on the T cells was shown
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[2, 6, 63]. Therefore as done for filaria infection the outcomes for history of
malaria in pregnancy were corrected for filaria infection status using the multiple
regression analysis. This shows the independent effect of episode of malaria
during pregnancy on the distribution of percentages of CD4+ cells and CD4+
cells expressing FOXP3, Tbet and Ror T (Table 9).
In women with a malaria episode during pregnancy the regulatory T cells
( =0.839, p=0.019) were significantly higher then in those without an malaria
episode. No difference was observed comparing the CD4+ cells ( =3.504,
p=0.404) and CD4+ cells expressing Tbet ( =0.060, p=0.334) and Ror T
( =-0.055, p=0.140).
Table 9: Independent effect of filaria and malaria infection status of the mother on
the distribution of T cell subsets in their newborns
 CD4+ T cells T reg cells Th1 cells Th17 cells 
Factor Baseline Category 
β  
(95% CI) P 
β  
(95% CI) P 
β  
(95% CI) P 
β  
(95% CI) P 
Filaria 
 
Negative 
(15) 
 
Positive 
(15) 
3.504 
(-4.99 to 11.99) 
0.404 
0.625 
(-0.06 to 1.31) 
0.073 
0.060 
(-0.066 to 0.186) 
0.334 
-0.055 
(-0.13 to 0.02) 
0.140 
Malaria in 
pregnancy 
 
No 
(17) 
 
Yes 
(13) 
-1.676 
(-10.25 to 6.89) 
0.691 
0.839 
(0.15 to 1.53) 
0.019 
-0.075 
(-0.202 to 0.052) 
0.236 
-0.013 
(-0.09 to 0.06) 
0.718 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The strength of the association between two variables is given by the value of the
regression coefficient beta ( ) value. A positive  -value indicates a positive association
between the variables, while a negative  -value indicates a negative association. p
values are given to indicate the statistical significance of the associations.
3.5 Association between regulatory T cells and Th1 and Th17
cell subsets in children born from filaria infected and
uninfected mother
In order to investigate the association between regulatory T cells and the
different T helper subsets, the association between CD4+CD25highFOXP3+ and
CD4+Tbet+, CD4+ROR T+ cells was examined through a linear regression
analysis (Figure 8). Analyzing all subsets together a negative association
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between regulatory T cells and CD4+Tbet+ T cells ( =-0.149, 95% CI= -0.256
to -0.043, p=0.008) or CD4+ROR T+ T cells ( =-0.175, 95% CI= -0.275 to
-0.074, p=0.001) was observed. After stratifying our study subjects by their filaria
infectious status this negative association between the regulatory T cells and Th1
( =-0.242, p=0.002) or Th17 ( =-0.170, p=0.013) was only observed in the filaria
infected group. In the filaria uninfected group no significant negative association
was seen between regulatory T cells and Th1 cells ( =0.012, p=0.888) and Th17
cells ( =-0.142, p=0.177).
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Figure 8: Association between regulatory T cells and Th1 and Th17 cell subsets
in children born from filaria infected and uninfected mother
The relation between CD4+CD25highFOXP3+ cells and CD4+Tbet+ cells (upper panel)
as well as CD4+CD25highFOXP3+ cells and CD4+ROR T+ cells (lower panel) of CBMC
of neonates from filaria negative (in grey) and filaria positive (in black) mothers assessed
by a linear regression analysis. Each dot shows a single subject while the solid lines
represent the regression lines of the model. The strength of the association between two
variables is given by the value of the regression coefficient beta (  represented by B in
our graph) value in each graph. A positive   value indicates a positive association
between the variables in the model, while a negative   value indicates a negative
association. p values are given to indicate the statistical significance of the associations.
46
4 Discussion
This exploratory study was designed to investigate the effect of in utero exposure
to filarial antigen on the expression of T helper cell populations in cord blood. For
this the percentages of CD4+ T cells and CD4+ T cells expressing Tbet, ROR T
and FOXP3 were measured in CBMC from filaria infected and uninfected mothers.
Helminths including filariasis are very common infections in the developing world
[81, 9, 10]. Their ability to chronically infect their human host for decades is linked
to their strong immune down regulatory function. Parts of this down regulatory
function are caused by CD4+ T cells. By producing cytokines and co-stimulatory
signals CD4+ T cells are able to influence the function and responsiveness of
the immune system to different antigens. Especially the regulatory T cells are of
great importance for this immune modulation [5]. Previous studies have shown
that chronic filaria infection in adults induces regulatory T cells and alternatively
activated macrophages, which then lead to a suppression of the Th1 and Th2
cells [2, 61]. Increasing evidence suggests that this down-regulatory effect does
not just apply to adults, but during pregnancy can even extend to the child.
Children born to filaria-infected mothers seem to have increased susceptibility to
filarial infection leading to earlier infection in life, higher parasite loads and fewer
disease manifestations [2, 3, 4]. Several studies from different areas indicate
that children born to filaria infected mothers display a biased immune response
to filaria antigens, with higher levels of the down regulatory IL-10 and IgG4
as well as a reduced T lymphocyte responsiveness [2, 63, 82, 83, 84]. In our
study no significant effect of filaria infection status on the percentages of CD4+
T cells, regulatory T cells, Th1 cells and Th17 cells was found. Other studies
reported higher levels of IL-10 which would go in line with increased Treg cells
[6, 85]. We were not able to reproduce those results, which might be due to the
limiting factors reported below, like the possibility of other geohelminth infections
of the mother or the low specificity/sensitivity of the Leuko-concentration method
used to detect the mf. A study in Kenya by Malhotra et al. found that maternal
Wucheria Bancrofti infection leads to an increase in IL-5 skewing the child’s
immune response towards Th2, while no differences were found for the levels
of the Th1 cytokines IL-2 and IFN-  [3]. While another study by Steel et al.
comparing Polynesian adolescents born to microfilaremic and uninfected mothers
showed that the infected group had lower levels of the Th1 cytokines IL-2, IL-5 and
IFN  [84]. These finding compare with our result seeing no increase in Th1 cells
and the negative correlation between Treg and Th1 cells in the infected group.
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Unfortunately we were not able to reproduce the result of a possible increase
in Th2 cells as the respective data was not usable (see Material and Methods,
Flowcytometry analysis).
Continuing our analysis looking at the association between the regulatory T cells
and Th1 and Th17 cells a negative correlation of Treg with Tbet and ROR T
cells was found to be significant only in the infected group. This correlation was
not found in the filaria uninfected group and might be explained by a stronger
functional activity of the regulatory T cells in infected individuals. This finding
compares to a study by Wammes et al. [86], where frequencies and function of
CD4+CD25highFOXP3+ regulatory T cells in geohelminth infected and uninfected
induviduals were compared. This study described that while the frequencies of
regulatory T cells between the two groups were similar their suppressive activity
was more pronounced in the geohelminth infected group [86]. The same result
was found for lymphatic filariasis [46]. This in combination with our data might
suggest that an activation of CD4+CD25highFOXP3+ regulatory T cells occurs
upon exposure of the cell to parasite antigens leaving them with strong functional
capacity.
Similar to filaria infection previous studies have shown that infants born to malaria
infected mothers have a higher post natal risk for an acute malaria episode
and also show a higher prevalence for blood parasites [87, 88]. In this context
several studies investigated the effect of malaria during pregnancy on the immune
system. Our findings that regulatory T cells were increased in cord blood from
mothers with at least one episode of malaria during pregnancy went in line with
findings from other studies. A study by Malhotra et al. [78] showed that children
frommothers with placental malaria demonstrated high levels of IL-10 in response
to in-vitro stimulation. Three other studies using in-vitro depletion were able to
demonstrate the involvement of regulatory T cells in this process, leading to a
restriction of the Th1 cytokine IFN  [78, 79, 80]. In all those studies the mothers
presented with either placental malaria or were malaria positive at birth. In our
study all mothers were free of malaria infection at the time of birth showing
that this immune priming effect of malaria infection can already take place in
earlier pregnancy. Furthermore we were not able to observe a decrease in Th1
percentages like in the studies mentioned before. This might be due to the fact
that the mothers in the malaria infected group were both primi and multi parus. A
study published by Malhotra et al. [89], which was looking at the effect of placental
malaria on T cell population in babies described that babies born to first time
mothers present with a Th1 or a mixed Th1 and Th2 response, while babies from
48
multiparus mothers show a Th2 response to these parasite antigen [89].
At the time of birth the immune system has not completely matured and full
maturation is only reached in the first childhood years. Therefore the immune
system of term infants shows a reduced innate as well as adaptive immunity. The
status of preterm birth (< 37 weeks of gestation) can increases this effect. Preterm
children show lower production of cytokines which limits T cell activation [58]. In
our study we were able to show a significant negative correlation of gestational
age and CD4+ T cells. This finding has been reported in a study by Series et
al. where preterm infants showed higher levels of CD4+ cells compared to term
infants [90]. Another study published in 2014 demonstrated a negative correlation
between gestational age and regulatory T cells [91]. Even though this correlation
was not significant in our analysis a trend for a negative correlation was observed.
The positive correlation of gestational age and Th1 as well as Th17 subsets might
be explained by the Th2 bias during pregnancy. During fetal life the fetal cytokine
response is driven toward Th2 restricting the pro-inflammatory Th1 cells. This
bias is thought to be pretentious of fetal rejection by the mothers immune system
[58]. With increasing gestational age the bias might decrease leading to higher
numbers of Th1 as well as Th17 cells as shown in our study.
There were some limitations to this study the most obvious being the small
sample size that might have prevented the detection of significant differences in
percentage of CD4+, Th1, Th17 and Treg populations. Also the not usable data for
the Th2 cells leaves questions open considering the extend of their involvement
in the immune response.
Another factor that we did not consider to the necessary extend was the bias
of co-infections like intestinal helminths and other parasite infections. Knowing
that all infections experienced during pregnancy may have an effect on the child’s
immune response those possible infections might have influenced our data and
influenced the levels of significance. But considering the high prevalence of these
parasitic infections in the study area, their distribution in the study population was
assumed to be homogenous. Additionally to those limiting factors the question
has to be raised whether the leuko-concentration method is a suitable enough
test to determine the filaria infection status, as it only is positive when patients
present with mf in blood. Due possibility of amicrofilaremic infection there is a
chance of not finding mf even though the mother was infected. This may have lead
to filaria infected subjects hiding in the uninfected group leading to a decrease
in significance. The analysis for specific IgE or IgG in cord blood to determine
whether the newborn was exposed might be a suitable possibility to overcome
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this limitation.
Nevertheless this thesis was able to show that offspring born to filaria infected
mothers have regulatory T cells that are negatively associated with Th1 and Th17
cells. These alterations caused by maternal helminth infection may lead to a
poor immunological response to future antigens encountered and vaccinations
administered during the first years of life and thus leaving the children at higher
risk for childhood infections.
In the future it might be interesting to consider whether women in the childbearing
age should be screened and treated for L. loa and M. perstans before a possible
pregnancy. This would allow the child’s immune response to develop without the
down regulatory limitations that could be detrimental for its health.
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5 Summary
5.1 Summary English
There is increasing evidence that maternal infections during pregnancy can affect
the developing immune system even if no vertical transmission is taking place.
Examining filaria infection different studies have shown evidence that the immune
deviation already starts in utero and children born to filaria-infected mothers seem
to have increased susceptibility to filarial infection.
In this study 30 pregnant women were recruited, examined for their filaria infection
status and divided into two homogenous groups, filaria infected and uninfected. At
delivery, cord blood mononucleated cells were obtained and the CD4+ cells were
phenotyped by expression of the transcription factors Tbet, RoR T and FOXP3.
No significant differenced in percentage of CD4+ cells, regulatory cells, Th1 and
Th17 cells were observed comparing the filaria infected with the uninfected group.
However in the infected group only there was a negative association between
CD4+CD25highFOXP3+ T cells and CD4+Tbet+ T cells (B=-0.242, p=0.002) as
well as CD4+ROR t+ T cells (B=-0.170, p=0.013).
Those results suggest that filaria infection during pregnancy leads to an
expansion of functionally active regulatory T cells in the child that keep Th1 and
Th17 cells under control. As a secondary outcome it was possible to reproduce
a previous finding that malaria infection during pregnancy leads to an increase in
regulatory T cells.
These alterations caused by maternal helminth and malaria infection may lead to
a poor immunological response to future antigens encountered and vaccinations
administered during the first years of life and thus leaving the children at higher
risk for childhood infections.
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5.2 Summary German
Nach heutigem Stand der Forschung gibt es zunehmende Hinweise dafür,
dass Infektionen während der Schwangerschaft einen Einfluss auf das
sich entwickelnde Immunsystem des Fötus haben. Dieser Effekt besteht
unabhängig von einer vertikalen Übertragung des Erregers auf das Kind.
Verschiedene Studien, welche sich mit der Infektion durch Filarien während der
Schwangerschaft beschäftigt haben, beschreiben, dass der Einfluss auf das
Immunsystem des Kindes schon im Mutterleib zu beobachten ist, und dass für
Kinder von Filarien infizierten Müttern ein erhöhtes Risiko einer Filarieninfektion
besteht.
Für die hier beschriebene Studie wurden 30 schwangere Frauen rekrutiert,
auf ihren Filarieninfektionsstatus untersucht und in zwei homogene Gruppen
unterteilt: infiziert und nicht infiziert. Bei der Geburt wurden die mononukleären
Zellen aus dem Nabelschnurblut isoliert und die CD4+ Zellen wurden auf die
Expression der Transkriptionsfaktoren Tbet, RoR T und FOXP3 hin analysiert.
Es wurden keine signifikanten Unterschiede in den Anteilen von CD4+
Zellen, regulatorischen T Zellen , Th1 und Th17 Zellen zwischen den beiden
Testgruppen beobachtet. In der Filarien infizierten Gruppe wurde jedoch eine
negative Assoziation zwischen CD4+CD25highFOXP3+ Zellen und CD4+Tbet+ T
Zellen (B=-0.242, p=0.002) sowie CD4+ROR t+ T Zellen (B=-0.170, p=0.013)
gefunden. Diese war in der nicht infizierten Gruppe nicht vorhanden. Diese
Ergebnisse legen nahe, dass eine Filarieninfektion während der Schwangerschaft
beim Kind zu einer vermehrten Aktivierung von regulatorischen T Zellen führt,
welche die Th1 und Th17 Zellen unter Kontrolle halten.
Im Weiteren konnten durch die Studie frühere Ergebnisse reproduziert werden,
welche zeigten, dass eine Malariainfektion während der Schwangerschaft zu
einem Ansteigen der regulatorischen T Zellen führt.
Die Veränderungen des Immnsystems, welche durch eine Infektion mit
Helminthen und Malariaerregern, verursacht werden, können während der ersten
Lebensjahre des Kindes zu einer verminderten Immunantwort gegenüber neuen
Antigenen bzw. Impfungen führen. Dies hat ein erhöhtes Infektionsrisiko für die
betroffenen Kinder zur Folge.
52
6 Appendix
List of Figures
1 L. loa life-cycle [17] . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2 Mansonella perstans life-cycle [18] . . . . . . . . . . . . . . . . . . 14
3 Th subsets [47] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
4 Map of the Republic of Gabon [73] . . . . . . . . . . . . . . . . . . 24
5 Markers used for FACS-Analysis . . . . . . . . . . . . . . . . . . . 30
6 Plate arrangement for FACS-Staining . . . . . . . . . . . . . . . . . 30
7 Gating example FlowJo . . . . . . . . . . . . . . . . . . . . . . . . 32
8 Association between regulatory T cells and Th1 and Th17 cell
subsets in children born from filaria infected and uninfected mother 46
List of Tables
2 Inclusion and Exclusion criteria . . . . . . . . . . . . . . . . . . . . 25
3 Apparatus list . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
4 Material list . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
5 Chemical list - 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
6 Chemical list - 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
7 Comparison of study groups . . . . . . . . . . . . . . . . . . . . . . 40
8 The distribution of T cell subsets of newborns in relation with
demographic factors and the infection status of their mother . . . . 42
9 Independent effect of filaria and malaria infection status of the
mother on the distribution of T cell subsets in their newborns . . . 44
References
[1] Kollmann TR Levy J Dauby N, Goetghebuer T and Marchant A. Uninfected
but not unaffected: chronic maternal infections during pregnancy, fetal
immunity, and susceptibility to postnatal infections. Lancet Infect Dis,
12(4):330–40, 2012.
53
[2] Saeftel M Hoerauf A, Satoguina J and Specht S. Immunomodulation by
filarial nematodes. Parasite Immunology, (27):417–429, 2005.
[3] Wamachi A Kioko J Mungai P Njzovu M Kazura JWMalhotra I, Ouma JH and
King CL. Influence of maternal filariasis on childhood infection and immunity
to wuchereria bancrofti in kenya. Infect Immun, 71(9):5231–7, 2003.
[4] Mungai PL Wamachi AN Kioko JM Ouma JH Muchiri E Gallagher M,
Malhotra I and King CL. The effects of maternal helminth and malaria
infections on mother-to-child hiv transmission. AIDS, 19(16):1849–55, 2005.
[5] Hartgers FC and Yazdanbakhsh M. Co-infection of helminths and malaria:
modulation of the immune responses to malaria. Parasite Immunol,
28(10):497–506, 2006.
[6] Webb EL Nampijja M Lyadda N Bukusuba J Kizza M Namujju PB Nabulime
J Ndibazza J Muwanga M Elliott AM, Mawa PA and Whitworth JA. Effects
of maternal and infant co-infections, and of maternal immunisation, on the
infant response to bcg and tetanus immunisation. Vaccine, 29(2):247–55,
2010.
[7] Gorak-Stolinska P Weir RE Floyd S Blitz R Mvula H Newport MJ Branson
K McGrath N Crampin AC Fine PE Lalor MK, Ben-Smith A and Dockrell
HM. Population differences in immune responses to bacille calmette-guérin
vaccination in infancy. J Infect Dis, 199(6):795–800, 2009.
[8] Adegnika AA and Kremsner PG. Epidemiology of malaria and helminth
interaction: a review from 2001 to 2011. Curr Opin HIV AIDS, 7(3):221–4,
2012.
[9] MD Richard L. Guerrant, MD David H. Walker, and MD Peter F. Weller.
Tropical Infectious Diseases: Principles, Pathogens and Practice, volume 3.
Churchill, Livingstone Elsevier, 3 edition, Philadelphia 2011.
[10] Onapa AW Simonsen PE and Asio SM. Mansonella perstans filariasis in
africa. Acta Trop, 120 Suppl 1:S109–20, 2011.
[11] Million M-Galimberti L Ferraris L Mandia L Trabucchi G Cacioppo V Monaco
G Tosoni A Brouqui P Gismondo MR Giuliani G Antinori S, Schifanella L and
Corbellino M. Imported loa loa filariasis: three cases and a review of cases
54
reported in non-endemic countries in the past 25 years. Int J Infect Dis,
16(9):e649–62, 2012.
[12] Stuart H. Ralston Nicki R. Colledge, Brian R. Walker, editor. Davidson’s
Principles and Practice of Medecine - 21st Edition. Churchill, Livingstone
Elsevier, 2010.
[13] Cox FEG. History of human parasitology. Clin Microbiol Rev, 15(4):595–612,
2002.
[14] Klion AD and Nutman TB. Tropical Infectious Diseases: Principles,
Pathogens and Practice; Chapter 105: Loiasis and Mansonella Infections.
Saunders Elvesier, 2006.
[15] Padgett JJ and Jacobsen KH. Loiasis: African eye worm. Transactions of
the Royal Society of Tropical Medicine and Hygiene, 102(10):983–9, 2008.
[16] Metzger WG and Mordmüller B. Loa loa-does it deserve to be neglected?
Lancet Infect Dis, 14(4), 2014.
[17] Centers for Disease Control and Prevention. Loa loa - life cycle, 2010.
[18] Centers for Disease Control and Prevention. Mansonella perstans - life cycle,
2013.
[19] Mark Walport Charles A. Janeway, Paul Travers and Mark Shlomchik.
Immunologie. Akademischer Verlag GmbH Heidelberg-Berlin, 5. auflage
edition, 2002.
[20] Zhu J and Paul WE. Cd4 t cells: fates, functions, and faults. Blood,
112(5):1557–69, 2008.
[21] Ronchese F Bouchery T, Kyle R and Le Gros G. The differentiation of
cd4(+) t-helper cell subsets in the context of helminth parasite infection. Front
Immunol, 5:487, 2014.
[22] O’Garra A and Vieira P. Regulatory t cells and mechanisms of immune
system control. Nat Med, 10(8):801–5, 2004.
[23] Mills KH. Regulatory t cells: friend or foe in immunity to infection? Nat Rev
Immunol, 4(11):841–55, 2004.
55
[24] Akdis CA and Akdis M. Mechanisms and treatment of allergic disease in the
big picture of regulatory t cells. J Allergy Clin Immunol, 123(4):735–46; quiz
747–8, 2009.
[25] Bond MW Giedlin MA Mosmann TR, Cherwinski H and Coffman RL. Two
types of murine helper t cell clone. i. definition according to profiles of
lymphokine activities and secreted proteins. J Immunol, 136(7):2348–57,
1986.
[26] Mosmann TR and Coffman RL. Th1 and th2 cells: different patterns of
lymphokine secretion lead to different functional properties. Annu Rev
Immunol, 7:145–73, 1989.
[27] Romagnani S. Lymphokine production by human t cells in disease states.
Annu Rev Immunol, 12:227–57, 1994.
[28] Lefebvre DE Webb J Chakir H, Wang H and Scott FW. T-bet/gata-3 ratio
as a measure of the th1/th2 cytokine profile in mixed cell populations:
predominant role of gata-3. J Immunol Methods, 278(1-2):157–69, 2003.
[29] Schlaak JF Schmitt E Meyer zum Büschenfelde KH Barbulescu K, Becker C
and Neurath MF. Il-12 and il-18 differentially regulate the transcriptional
activity of the human ifn-gamma promoter in primary cd4+ t lymphocytes.
J Immunol, 160(8):3642–7, 1998.
[30] Romagnani S. T-cell subsets (th1 versus th2). Ann Allergy Asthma Immunol,
85(1):9–18; quiz 18, 21, 2000.
[31] Chtanova T and Mackay CR. T cell effector subsets: extending the th1/th2
paradigm. Adv Immunol, 78:233–66, 2001.
[32] Zhu J Yagi R and Paul WE. An updated view on transcription factor
gata3-mediated regulation of th1 and th2 cell differentiation. Int Immunol,
23(7):415–20, 2011.
[33] Oukka M Bettelli E, Korn T and Kuchroo VK. Induction and effector functions
of t(h)17 cells. Nature, 453(7198):1051–7, 2008.
[34] Korn T Miossec P and Kuchroo VK. Interleukin-17 and type 17 helper t cells.
N Engl J Med, 361(9):888–98, 2009.
56
[35] Wang AY Crome SQ and Levings MK. Translational mini-review series on
th17 cells: function and regulation of human t helper 17 cells in health and
disease. Clin Exp Immunol, 159(2):109–19, 2010.
[36] Maggi E Romagnani S Cosmi L, Liotta F and Annunziato F. Th17 cells: new
players in asthma pathogenesis. Allergy, 66(8):989–98, 2011.
[37] Lacerda MV Fujiwara RT Bueno LL, Morais CG and Braga EM.
Interleukin-17 producing t helper cells are increased during natural
plasmodium vivax infection. Acta Trop, 123(1):53–7, 2012.
[38] Dong C. Th17 cells in development: an updated view of their molecular
identity and genetic programming. Nat Rev Immunol, 8(5):337–48, 2008.
[39] Hsueh EC Zhang Q Ma C Zhang Y Varvares MA Hoft DF Ye J, Huang X and
Peng G. Human regulatory t cells induce t-lymphocyte senescence. Blood,
120(10):2021–31, 2012.
[40] Shevach EM. Mechanisms of foxp3+ t regulatory cell-mediated suppression.
Immunity, 30(5):636–45, 2009.
[41] Nomura T Sakaguchi S, Yamaguchi T and Ono M. Regulatory t cells and
immune tolerance. Cell, 133(5):775–87, 2008.
[42] Dario A A Vignali, Lauren W Collison, Workman, and Creg J. How regulatory
t cells work. Nat Rev Immunol, 8(7):523–32, Jul 2008.
[43] Sugimoto A Tsuji-Takayama K Yamamoto M Otani T Inoue T Harashima A
Okochi A Motoda R Yamasaki F Orita K Nakamura S, Suzuki M and Kibata
M. Il-2-independent generation of foxp3(+)cd4(+)cd8(+)cd25(+) cytotoxic
regulatory t cell lines from human umbilical cord blood. Exp Hematol,
35(2):287–96, 2007.
[44] Yamamoto M-Harashima A Okochi A Otani T Inoue T Sugimoto A Toraya
T Takeuchi M Yamasaki F Nakamura S Tsuji-Takayama K, Suzuki M and
Kibata M. The production of il-10 by human regulatory t cells is enhanced
by il-2 through a stat5-responsive intronic enhancer in the il-10 locus. J
Immunol, 181(6):3897–905, 2008.
[45] Golab K-Wang XJ Marek-Trzonkowska N Krzystyniak A Wardowska A
Mills JM Trzonkowski P Grzanka J, Leveson-Gower D and Witkowski P.
57
Foxp3, helios, and satb1: roles and relationships in regulatory t cells. Int
Immunopharmacol, 16(3):343–7, 2013.
[46] Wiria AE Wibowo H Sartono E-Maizels RM Smits HH Supali T Wammes LJ,
Hamid F and Yazdanbakhsh M. Regulatory t cells in human lymphatic
filariasis: stronger functional activity in microfilaremics. PLoS Negl Trop Dis,
6(5):e1655, 2012.
[47] UpToDate. Human t helper cell subsets, 2014.
[48] Holt PG and Jones CA. The development of the immune system during
pregnancy and early life. Allergy, 55(8):688–97, 2000.
[49] Outram SV Crompton T and Hager-Theodorides AL. Sonic hedgehog
signalling in t-cell development and activation. Nat Rev Immunol,
7(9):726–35, 2007.
[50] Bodey B and Kaiser HE. Development of hassall’s bodies of the thymus
in humans and other vertebrates (especially mammals) under physiological
and pathological conditions: immunocytochemical, electronmicroscopic and
in vitro observations. In Vivo, 11(1):61–85, 1997.
[51] Siegel SE Bodey B, Bodey B Jr and Kaiser HE. Novel insights into the
function of the thymic hassall’s bodies. In Vivo, 14(3):407–18, 2000.
[52] Mathieson BJ and Fowlkes BJ. Cell surface antigen expression on
thymocytes: development and phenotypic differentiation of intrathymic
subsets. Immunol Rev, 82:141–73, 1984.
[53] Weissman IL Kraft DL and Waller EK. Differentiation of cd3-4-8- human fetal
thymocytes in vivo: characterization of a cd3-4+8- intermediate. J Exp Med,
178(1):265–77, 1993.
[54] Haynes BF. The human thymic microenvironment. Adv Immunol, 36:87–142,
1984.
[55] Yuksel B Hannet I Hulstaert F Hamilton C Mackinnon H Stokes LT
Munhyeshuli V Erkeller-Yuksel FM, Deneys V and Vanlangendonck F.
Age-related changes in human blood lymphocyte subpopulations. J Pediatr,
120(2 Pt 1):216–22, 1992.
58
[56] di Loreto M Felle R Ferrante M Papadia AM Porfido N Gambatesa V
Dell’Osso A Panaro A, Amati A and Lucivero G. Lymphocyte subpopulations
in pediatric age. definition of reference values by flow cytometry. Allergol
Immunopathol (Madr), 19(3):109–12, 1991.
[57] Hardaway LC Guloglu FB Ellis JS Jain R Divekar R Tartar DM Haymaker CL
Lee HH, Hoeman CM and Zaghouani H. Delayed maturation of an
il-12-producing dendritic cell subset explains the early th2 bias in neonatal
immunity. J Exp Med, 205(10):2269–80, 2008.
[58] Melville JM and Moss TJ. The immune consequences of preterm birth. Front
Neurosci, 7:79, 2013.
[59] Levy O. Innate immunity of the newborn: basic mechanisms and clinical
correlates. Nat Rev Immunol, 7(5):379–90, 2007.
[60] Ottesen EA McCarthy JS and Nutman TB. Onchocerciasis in endemic
and nonendemic populations: differences in clinical presentation and
immunologic findings. J Infect Dis, 170(3):736–41, 1994.
[61] Kumaraswami V Bab S, Blauvelt CP and Nutman TB. Regulatory networks
induced by live parasites impair both th1 and th2 pathways in patent
lymphatic filariasis: implications for parasite persistence. J Immunol,
176(5):3248–56, 2006.
[62] Babu S Metenou S and Nutman TB. Impact of filarial infections
on coincident intracellular pathogens: Mycobacterium tuberculosis and
plasmodium falciparum. Curr Opin HIV AIDS, 7(3):231–8, 2012.
[63] Adjobimey T and Hoerauf A. Induction of immunoglobulin g4 in human
filariasis: an indicator of immunoregulation. Ann Trop Med Parasitol,
104(6):455–64, 2010.
[64] Larbi J Satoguina JS, Weyand E and Hoerauf A. T regulatory-1 cells induce
igg4 production by b cells: role of il-10. J Immunol, 174(8):4718–26, 2005.
[65] Kubofcik J Semnani RT, Law M and Nutman TB. Filaria-induced immune
evasion: suppression by the infective stage of brugia malayi at the earliest
host-parasite interface. J Immunol, 172(10):6229–38, 2004.
[66] Auswertiges Amt Deutschland. Gabun.
59
[67] Foreign and Commonwealth Office. Gabon, 2012.
[68] Sophie Warne. Gabon, São Tomé and Príncipe: the Bradt Travel Guide.
Bradt, 2007.
[69] Padilla C Moussavou G Moukana H Mbou RA Ollomo B Akue JP, Nkoghe D
and Leroy EM. Epidemiology of concomitant infection due to loa loa and
mansonella perstans in gabon. PLoS Negl Trop Dis, 5(10):e1329, 2011.
[70] Gonzalez JP Nkoghe D, Akue JP and Leroy EM. Prevalence of plasmodium
falciparum infection in asymptomatic rural gabonese populations. Malaria
Journal, 10(1):33, 2011.
[71] Barcelona Centre for International Health Research (CRESIB). Annual
report 2011, 2011.
[72] Hospital Clinic of Barcelona. Evaluation of alternative antimalarial drugs for
malaria in pregnancy (mippad).
[73] Geographic Guide Africa. Map of gabon, 2014.
[74] Dennis DT and Kean BH. Isolation of microfilariae: report of a new method.
J Parasitol, 57(5):1146–7, 1971.
[75] WHO. Schistosomiasis.
[76] Kombila M Engel K Faucher JF Ngou-Milama E Planche T, Krishna S and
Kremsner PG. Comparison of methods for the rapid laboratory assessment
of children with malaria. The American journal of tropical medicine and
hygiene, 65(5):599–602, 2001.
[77] Stadecker MJWagner AD Plummer J Durant JL Kosinski KC, Bosompem KM
and Gute DM. Diagnostic accuracy of urine filtration and dipstick tests
for schistosoma haematobium infection in a lightly infected population of
ghanaian schoolchildren. Acta tropica, 118(2):123–7, 2011.
[78] Mungai P Koech D Muchiri E Mackroth MS, Malhotra I and King CL. Human
cord blood cd4+cd25hi regulatory t cells suppress prenatally acquired t cell
responses to plasmodium falciparum antigens. J Immunol, 186(5):2780–91,
2011.
[79] Morgan WD Holder AA Pinder M Bisseye C, van der Sande M and Ismaili J.
Plasmodium falciparum infection of the placenta impacts on the t helper type
60
1 (th1)/th2 balance of neonatal t cells through cd4(+)cd25(+) forkhead box
p3(+) regulatory t cells and interleukin-10. Clin Exp Immunol, 158(3):287–93,
2009.
[80] Kramer M Hartgers FC Kremsner PG Krzych U Brustoski K, Moller U and
Luty AJ. Reduced cord blood immune effector-cell responsiveness mediated
by cd4+ cells induced in utero as a consequence of placental plasmodium
falciparum infection. J Infect Dis, 193(1):146–54, 2006.
[81] WHO. Fact sheet no94 - malaria, 2014.
[82] Schulz-Key H Pit DS, Polderman AM and Soboslay PT. Prenatal immune
priming with helminth infections: parasite-specific cellular reactivity and th1
and th2 cytokine responses in neonates. Allergy, 55(8):732–9, 2000.
[83] Calvopiña M Paredes W Araujo E Guderian RH Bradley JE Elson LH, Days A
and Nutman TB. In utero exposure to onchocerca volvulus: relationship to
subsequent infection intensity and cellular immune responsiveness. Infect
Immun, 64(12):5061–5, 1996.
[84] McCarthy JS Steel C, Guinea A and Ottesen EA. Long-term effect of prenatal
exposure to maternal microfilaraemia on immune responsiveness to filarial
parasite antigens. Lancet, 343(8902):890–3, 1994.
[85] Mungai PL Malhotra I, Kioko JM Ouma JH Muchiri E Kazura JW
Wamachi AN, Tisch D, and King CL. Prenatal t cell immunity to wuchereria
bancrofti and its effect on filarial immunity and infection susceptibility during
childhood. J Infect Dis, 193(7):1005–13, 2006.
[86] Wiria AE de Gier B Sartono E Maizels RM Luty AJ Fillié Y Brice GT Supali
T Smits HH Wammes LJ, Hamid F and Yazdanbakhsh M. Regulatory t
cells in human geohelminth infection suppress immune responses to bcg
and plasmodium falciparum. Eur J Immunol, 40(2):437–42, 2010.
[87] Breitling LP Gabor J Agnandji ST Newman RD Lell B Issifou S
Yazdanbakhsh M Luty AJ Kremsner PG Schwarz NG, Adegnika AA and
Grobusch MP. Placental malaria increases malaria risk in the first 30 months
of life. Clin Infect Dis, 47(8):1017–25, 2008.
[88] Personne P Fievet N Dubois B Beyemé M Boudin C Le Hesran JY, Cot M
and Deloron P. Maternal placental infection with plasmodium falciparum
61
and malaria morbidity during the first 2 years of life. Am J Epidemiol,
146(10):826–31, 1997.
[89] Muchiri E Ouma J Sharma S Kazura JW Malhotra I, Mungai P and King
CL. Distinct th1- and th2-type prenatal cytokine responses to plasmodium
falciparum erythrocyte invasion ligands. Infect Immun, 73(6):3462–70, 2005.
[90] Carrier C Masson M Bédard PM Beaudoin J Sériès IM, Pichette J and Hébert
J. Quantitative analysis of t and b cell subsets in healthy and sick premature
infants. Early Hum Dev, 26(2):143–54, 1991.
[91] Ruiz R Llorens-Bonilla BJ Martinez-Lopez DG Funderburg N Luciano AA,
Arbona-Ramirez IM and Dorsey MJ. Alterations in regulatory t cell
subpopulations seen in preterm infants. PLoS One, 9(5):e95867, 2014.
62
7 Erklärung zum Eigenanteil der
Dissertationsschrift
DIe Konzeption der Studie erfolgte in Zusammenarbeit mit Prof. Dr. M.
Yazdanbakhsh (Department of parasitology, LUMC), Dr. U. Ateba Ngoa
(Department of parasitology, LUMC) and Dr. G. Mombo Ngoma (Centre de
Recherches Médicales de Lambaréné).
Dr. U. Ateba Ngoa hat mir bei der Auswahl der statistischen Tests geholfen, die
Arbeit betreut und Korrektur gelesen.
Frau L. van der Vulgt (Department of parasitology, LUMC) hat mich in die Arbeit
im Labor eingelernt und die FACS-Messungen gemeinsam mit mir durchgeführt.
Die Patientenbehandlung und Entnahme des Nabelschnurblutes wurde von den
Mitarbeitern der MiPPAD-Studie durchgeführt.
Die folgenden Arbeiten wurden von mir eigenständig durchgeführt:
– Rekrutierung, Blutentnahme, Filariendiagnostik und Datenerhebung
– Durchführung der Zellisolation und fixierung
– Auswertung und statistische Analysen
Ich versichere das Manuskript selbstständig verfasst zu haben und keine weiteren
als die von mir angegebenen Quellen verwendet zu haben.
63
8 Publikation
Ateba-Ngoa U, Mombo-Ngoma G, Zettlmeissl E, van der Vlugt LE, de Jong S,
Matsiegui PB, Ramharter M, Kremsner PG, Yazdanbakhsh M and Adegnika AA.
CD4+CD25hiFOXP3+ Cells in Cord Blood of Neonates Born from Filaria Infected
Mother Are Negatively Associated with CD4+Tbet+ and CD4+ROR t+ T Cells.
PLoS One. 2014 Dec 22;9(12):e114630. doi: 10.1371/journal.pone.0114630.
eCollection 2014.
64
9 Acknowledgment
I want to thank Prof. Dr. G. Kremsner for the opportunity to perform this thesis at
his Institute and for enabling the stay and cooperation in the Research laboratory
of the Albert Schweitzer Hospital in Lambaréné.
My special thanks go to Prof. Dr. M. Yazdanbakhsh for taking me under her
wings, supporting and helping me and allowing me to come to Leiden twice for
performing measurements and statistical analysis.
I want to thank Dr. U. Ateba Ngoa for supervising my work in Gabon and Leiden
and all the time and excellent effort he put into the corrections.
I want to thank Luciën van der Vlugt and Sanne de Jong for instructions in the
laboratory and the support with the FACS measurements.
Additionally I want to thank all the employees and students of the Research
laboratories in Fougamou, Lambaréné and Leiden for the very good collaboration.
Very special thanks go to the study participants for their cooperation and
participation.
Last but not least I want to thank my parents and my brother for their love, help
and support during my studies, while working on this thesis and throughout my
whole life.
This is an European Union funded project : An African-European Research
Initiative (IDEA)” (HEALTH-F3-2009-241642)
65
